BCPPs desiring an evidence-based, in-depth review of contemporary issues in psychiatric pharmacy at the specialist level are the intended audience of this recertification activity. This activity is designed for BCPPs who are auditory and visual learners and/or who learn best from hands-on-learning and dialoguing with specialist faculty and colleagues.
Content
The Clinical Application Series is an application-based continuing pharmacy education (CPE) activity designed to improve competency of participants. An application-based CPE activity requires that participants apply the information learned. In an application-based CPE activity, the learning objectives are written at a higher level in order to assess the learner's ability to use the information that is learned, at the expected level of practice of Board Certified Psychiatric Pharmacists. The examination for this product often features case studies requiring that the participant apply the principles learned through the sessions.
The Clinical Application Series includes:
Online access to the recorded speakers' audio presentations synchronized with their slide presentations (presented live at AAPP 2023 April 16 and April 17 in Atlanta, GA).
For pharmacists, 5 hours of ACPE credit and 5 hours of BCPP Recertification credit achieved by successfully completing the online AAPP recertification examination.
Access to the AAPP testing center with exam submission due on or before October 16, 2023.
Course Requirements
To satisfactorily complete the Clinical Application Series and receive 5 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:
Abide by a confidentiality and honesty statement requiring individual completion of the Recertification education.
Complete an online assessment on or before the deadline of October 16, 2023.
Receive a passing score (76%) as determined by a panel of experts.
Completion of an activity evaluation form.
Partial credit is not available for individual topics within the programming; it is either all 5 hours of Clinical Application Series credit or none.
You will proceed through the following steps to satisfactorily complete this course:
Sign in (or create a FREE account).
Register for this course.
Complete the pre-test before starting the activity.
Review the full content of the activity and reflect upon its teachings.
Complete the post-test at the end of the activity no later than the closing activity date.
Complete the evaluation at the end of the activity.
Wait for the official review of exam questions within 4 weeks following the closing date.
Receive a passing grade (76%).
Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Credit is awarded in the calendar year the assessment is completed. AAPP reports continuing credit for ACPE (CPE Monitor) and BCPP Recertification (BPS) within days of successful exam completion.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended,
or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat
or FoxIt
An adequate device and Internet connection:
Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent);
Memory: 4 GB;
Storage: 5 GB available;
Internet speed: 4.0 Mbps (up/down)
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Faculty Information
Jason Bonner, PhD Mary Borovicka, PharmD, BCPP Veldana Alliu, PharmD, BCPS Tera Moore, PharmD, BCPS, BCACP Ian McGrane, PharmD, BCPS, BCPP Ericka Crouse, PharmD, BCPP, BCGP
Jason E. Bonner, PhD
Clinical Health Psychologist, Consultant for the VHA Pharmacy Residency Program Office
US Department of Veterans Affairs
Chapel Hill, NC
Dr. Jason E. Bonner is a Clinical Health Psychologist in Primary Care-Mental Health Integration with the U.S. Department of Veterans Affairs at the Durham VA Health Care System. He is the Consultant Psychologist for the Veterans Health Administration’s (VHA) Pharmacy Residency Program Office (PRPO) and the only non-pharmacy member of the VHA Pharmacy Residency Advisory Board providing guidance on issues intersecting wellness and pharmacy training.
He is a subject matter expert on topics of stress, burnout, coping, well-being, and resilience for pharmacy residency training. His direct consultative and programmatic support serves to address these issues in both residents and preceptors/program directors to help develop and maintain a more resilient pharmacy workforce.
Dr. Bonner is a regularly invited speaker to local and national VA pharmacy residency programs as well as national pharmacy practice conferences. He is a Veteran of the United States Air Force and lives in Chapel Hill, North Carolina with his family and German Shepherd, Roxy.
Mary Borovicka, PharmD, BCPP
Clinical Pharmacist-Dept of Psychiatry
MetroHealth Medical Center
Cleveland, OH
Dr. Borovicka earned her BS in Pharmacy in 1989 and her Doctor of Pharmacy degree at the University of Toledo College of Pharmacy and Pharmaceutical Sciences in 1995. She completed her Psychiatric Pharmacy Practice Residency in 1996 at the Louis Stokes Veterans’ Affairs Medical Center (RPD Matthew Fuller, Pharm.D., FASHP, BCPP). She moved on to the University of Maryland as a clinical assistant professor and psychiatric pharmacist at Spring Grove Hospital Center from 1996-2000. From there, she joined the faculty at the University of Toledo College of Pharmacy and Pharmaceutical Sciences (UTCPPS) and was a tenured associate professor until 2020. She was responsible for coordinating the therapeutics courses in psychiatry, neurology, and substance use disorders in the college. In addition, Dr. Borovicka served as the Director of the ACPE accredited Continuing Professional Education Program for 14 years at UTCPPS. In June 2020, she joined MetroHealth Medical Center in Cleveland, Ohio as a psychiatric pharmacist for both the departments of pharmacy and psychiatry where she is the first psychiatric pharmacist in the organization. She has been active in training PGY1 and PGY2 pharmacy residents, APPE students from pharmacy schools all over Ohio as well as psychiatry, family medicine, and internal medicine residents. Dr. Borovicka coordinated the development of an esketamine clinic for MetroHealth and is responsible for management of the REMS program. She also conducts research and is active on several hospital committees. She was awarded Outstanding Professor of the Year while at UTCPPS and was MetroHealth’s Preceptor of the Year in 2021. She has authored several journal articles and book chapters.
Dr. Borovicka teaches in the long-acting injectable continuing education program provided by the Ohio Pharmacists Association (OPA) and has assisted in the certification of over 300 Ohio pharmacists in the administration of long-acting injectable agents.
Dr. Borovicka is an active member of AAPP and is currently a member of the AAPP Foundation Board. She served on the AAPP Board of Directors as the Treasurer from 2009-2011, was on the Editorial Boards for the Recertification Committee and the From Theory to Practice Committee, and was a member of the Recertification Review Course Committee from 2003-09 (Chair from 2007-09).
Veldana Alliu, PharmD, BCPS
National Program Manager, Clinical Practice Integration and Model Advancement, Pharmacy Benefits Management, Clinical Pharmacy Practice Office
Veterans Health Administration
Dr. Veldana Alliu is a National Pharmacy Program Manager for Clinical Practice Integration and Model Advancement with the Veteran Health Administration (VHA) Pharmacy Benefits Management (PBM) Clinical Pharmacy Practice Office (CPPO). Dr. Alliu received completed her education at the University of Florida where she received Bachelor of Science in Chemistry and Bachelor of Arts in Anthropology before receiving her Doctor of Pharmacy. She completed a PGY-1 Pharmacy Practice Residency at the North Florida/South Georgia Veterans Health System in Lake City, FL and PGY-2 in Health-System Pharmacy Administration at the Ralph H. Johnson VA Medical Center in Charleston, SC.
In her current role, Dr. Alliu serves as a national pharmacy subject matter expert supporting clinical pharmacy practice in Substance Use Disorders. Her role includes spearheading optimization, integration, and standardization of Clinical Pharmacist Practitioners (CPPs) in direct patient care roles to improve Veteran access comprehensive medication management services. She is actively involved in both the American Society of Health-System Pharmacists (ASHP) and the Florida Society of Health-System Pharmacists (FSHP). Within FSHP, she is the education coordinator within her regional chapter and was appointed to the state’s Ambulatory Care Clinical Council. Dr. Alliu has worked for the VA for over 10 years as a Clinical Pharmacist Practitioner and Clinical Pharmacy Leader before joining CPPO in 2019.
Tera Moore, PharmD, BCACP
National PBM Program Manager
Clinical Practice Integration and Model Advancement Pharmacy Benefits Management (PBM)
Aurora, CO
Tera Moore, Pharm.D., BCACP has served the VA for over 19 years and is the National Program Manager for Clinical Practice Integration and Model Advancement with the Department of Veterans Affairs Pharmacy Benefits Management Services, Clinical Pharmacy Practice Office (CPPO). In this role, Dr. Moore develops and manages initiatives that aid in demonstrating the value and criticality of advancing clinical pharmacy practice across VA facilities. She has a particular emphasis on program development, implementation and outcomes assessments designed to evaluate the impact of clinical pharmacy services impact on the quadruple aim of health care including better care, reduced health care costs, improved patient experience and provider well-being in Mental Health, Suicide Prevention, Substance Use Disorders and Neurology. As a component of support for clinical pharmacist practitioners and clinical pharmacy leaders, she leads the innovative mentorship and coaching efforts. These programs provide clinical pharmacy practitioners and clinical pharmacy leaders the skills and support to transform clinical pharmacy practice to the changing needs of patients as part of a high reliability organization.
Dr. Moore received her Doctor of Pharmacy degree from the University of New Mexico and completed an ASHP-accredited Ambulatory Care Specialty residency at the South Texas Veterans Health Care System (STVHCS) in San Antonio, TX. She is a Board Certified Ambulatory Care Pharmacist. Dr. Moore’s experience spans across clinical practice, residency program director and leadership roles including Associate Chief for Clinical Pharmacy Services and Acting Chief of Pharmacy. Dr. Moore is a past recipient of the Certificate of Commitment from the VHA Acting Deputy Undersecretary for Patient Care Services, the VHA Under Secretary for Health Pharmacy Benefits Management Innovation Award and the PBM CPPO was awarded the ASHP Board of Director’s Award of Excellence. She was a member of the National Quality Forum’s National Quality Partners™ Serious Mental Illness Action Team in 2019 and has given multiple presentations reflecting her expertise in clinical pharmacy practice and leadership. She also has authored a number of peer-reviewed publications. She is a long-standing, active member of professional associations including the American Society of Health System Pharmacists (ASHP) and the American Association of Psychiatric Pharmacists (AAPP). As part of these organizations, she is a member of the ASHP Council on Education and Workforce Development and the AAPP Professional Affairs Committee, Core Outcomes Set Task Force and Workforce Development Paper Task Force.
Ian McGrane, PharmD, BCPS, BCPP
Associate Professor
University of Montana
Missoula, MT
Dr. McGrane graduated with a doctor of pharmacy degree from the University of Montana in 2011 and completed residency at the Western Psychiatric Institute of the University of Pittsburgh Medical Center and then the Captain James A. Lovell Federal Health Care Center in North Chicago, Illinois. He is currently an associate professor at the University of Montana’s Skaggs School of Pharmacy, with a clinical practice site at the Neurobehavioral Medicine Inpatient Unit of Providence St. Patrick Hospital in Missoula.
While the majority of his scholarly work are related to therapeutic drug monitoring and drug-drug interactions of psychiatric medications, some of his early review articles surrounded the use of melatonin for various indications. These projects stemmed from performing a formulary review at his PGY1 residency program and continued mentorship by Jonathan Leung and Shelby Corman. Most recently, Dr. McGrane has co-authored two continuing education book chapters on sleep-wake disorders for ACCP with the assistance of AAPP members Jonathan Lister and Caitlin McCarthy- who he would like to thank.
Faculty Disclosures
Financial: Honorarium from the American College of Clinical Pharmacy in 2021 and 2022 as author for PSAP and ACSAP Continuing Education programs for the book chapters titled “sleep-wake disorders” (same title for both books)
Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: gabapentin, trazodone, lorazepam, melatonin, quetiapine, lurasidone, and mirtazapine for insomnia disorder; Pitolisant for excessive daytime sleepiness in patients with obstructive sleep apnea
Ericka L. Crouse, PharmD, BCPP, BCGP
Associate Professor
Virginia Commonwealth University
Richmond, VA
Ericka Crouse is an Associate Professor in the Department of Pharmacotherapy and Outcomes Sciences at the Virginia Commonwealth University in Richmond, Virginia. Her clinical practice sites include inpatient psychiatry and an outpatient substance use disorder clinic. Dr. Crouse received her PharmD degree from the University of Florida. She completed a Geriatrics Specialty Residency at the Durham VAMC in Durham, NC followed by a Specialty Residency in Psychiatric Pharmacy at the Virginia Commonwealth University Health System. Prior to transitioning to academia, she practiced full time as a Clinical Pharmacy Specialist on the inpatient psychiatry unit at VCUHS for over 10 years, and served as a PGY2 Psychiatric Residency Program Director. Dr. Crouse’s areas of interest include geriatric psychiatry including dementia and delirium; schizophrenia, mood disorders, acute agitation and substance use disorders. She is interested in patient safety and reduction of medication errors. Dr. Crouse has authored book chapters on dosage forms of psychiatric medications in textbooks focused on psychosomatic medicine.
She has been actively involved in AAPP since her residency and has served on a variety of committees, served as Secretary to the Board of Directors, and currently serves on the Substance Use Disorders Committee.
Learning Objectives
Topic
Burnout Among Psychiatric Pharmacists: A Discussion of Drivers and Evidence-Based/Informed Interventions to Improve Clinician Well-Being
Speaker: Jason Bonner, PhD
Learning Objectives:
Describe the dimensions, known drivers, and prevalence of burnout among clinical pharmacists.
Examine unique challenges in mental health that may contribute to burnout and reduced resilience among psychiatric pharmacists.
Propose individual- and organizational-level, evidence-based methods to mitigate and reduce burnout, improve engagement, and enhance overall well-being of psychiatric clinical pharmacists in the workplace.
Psychotropic REMS Programs: Benefits, Challenges, and Implementation
Speaker: Mary Borovicka, PharmD, BCPP
Learning Objectives:
Assess benefits and challenges with the use of REMS programs.
Compare REMS program requirements between different psychotropic medications.
Develop a psychiatric medication program that adheres to REMS requirements.
Stepping Up During Crisis: Leveraging Pharmacists to Expand Access to Mental Health and Substance Use Disorder Care
Assess how the COVID-19 pandemic impacted mental health/substance use disorder treatment standards and best practices.
Evaluate innovations implemented during the COVID-19 pandemic to improve access to mental health/substance use disorder care during a time of crisis.
Choose collaborative practice models that integrate pharmacist practitioners and enhance access to mental health/substance use disorder care.
New Medications for the Treatment of Sleep Disorders
Speaker: Ian McGrane, PharmD, BCPS, BCPP
Learning Objectives:
Compare newer medications for management of sleep disorders to those commonly prescribed in clinical practice.
Assess the role of new and emerging medications in the treatment of sleep disorders.
Formulate a treatment plan for the management of sleep disorders using new and emerging medications.
Beyond PO and IM: Novel Delivery Systems for Psychiatric Medications
Speaker: Ericka Crouse, PharmD, BCPP, BCGP
Learning Objectives:
Evaluate the pharmacokinetics and pharmacodynamics of novel delivery systems of psychotropic drugs.
Compare and/or contrast use and safety of novel delivery systems with traditional delivery systems.
Recommend strategies to adopt novel delivery systems into current practice.
Continuing Education Credit and Disclosures
Activity Dates:04/16/2023 - 10/18/2023 ACPE Contact Hours: 5 ACPE Numbers: 0284-0000-23-003-H99-P (Application), 0284-0000-23-004-H04-P (Application), 0284-0000-23-005-H04-P (Application), 0284-0000-23-006-H01-P (Application), 0284-0000-23-007-H01-P (Application) Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacists can obtain 5 hours of ACPE credit and 5 hours of BCPP Recertification credit by successfully completing the online Clinical Application Series examination.
The American Association of Psychiatric Pharmacists is approved as a Professional Development Provider for the Board Certified Psychiatric Pharmacist (BCPP) specialty by the Board of Pharmacy Specialties (BPS). This course is part of a 5 hour BCPP recertification product earned after successful completion of the associated BCPP recertification examination for the full product.
AAPP reports continuing credit for ACPE (CPE Monitor) and BCPP Recertification (BPS) within days of successful exam completion.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
Marissa Cullen, PharmD, BCPP
Clinical Pharmacist
UPMC Western Psychiatric Hospital
Pittsburgh, PA
No Relevant Financial Relationships to Disclose
Beth DeJongh, PharmD, BCPS, BCPP
Director of Continuing Professional Development
American Association of Psychiatric Pharmacists
Lincoln, NE
No Relevant Financial Relationships to Disclose
Alisha D. Donat, PharmD, BCPP
Clinical Pharmacy Specialist - Mental Health
South Texas Veterans Health Care System
San Antonio, TX
No Relevant Financial Relationships to Disclose
Traci M. Dutton, PharmD, BCPP, BCPS
Clinical Pharmacy Specialist - Mental Health; Program Director - PGY2 Psychiatric Pharmacy Residency
VA Tennessee Valley Healthcare System
Murfreesboro, TN
Employment: Tennessee Valley VA Healthcare System, Clinical Pharmacy Specialist - Mental Health, Member of VA PBM Educational Advisory
Committee which oversees Board Certification Study Groups
Megan J. Ehret, PharmD, BCPP, MS BCPP Program Director
Professor
University of Maryland
Baltimore, MD
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Saladex Biomedical Consultant, Lexi-Comp Consultant/Reviewer,
SMI Adviser; Pharmacist Consultant
Educational Grants, Research Grants or Contracts: FDA/University of Maryland CERSI, Maryland Behavioral Health Department, NIH
Abigail Hampton, PharmD, BCPP
Psychiatric Clinical Pharmacist - Ambulatory
University of Kansas Health System
Kansas City, KS
No Relevant Financial Relationships to Disclose
Jordan Haygood, PharmD, BCPP
Clinical Pharmacy Specialist - Psychiatry
Medical University of South Carolina
Charleston, SC
No Relevant Financial Relationships to Disclose
Courtney A. Iuppa, PharmD, BCPP
Clinical Pharmacy Manager & Residency Program Director
Center for Behavioral Medicine
Kansas City, MO
No Relevant Financial Relationships to Disclose
Archana R. Jhawar, PharmD, BCPP
Clinical Pharmacist
Jesse Brown VAMC/ UIC College of Pharmacy
Chicago, IL
No Relevant Financial Relationships to Disclose
Dongmi Kim, PharmD, BCPP, BCPS
Assistant Clinical Professor
Fairleigh Dickinson University School of Pharmacy
Florham Park, NJ
No Relevant Financial Relationships to Disclose
Jamie C. Kneebusch, PharmD, BCPP, BCPS
Assistant Clinical Faculty
UC San Diego, Skaggs School of Pharmacy
La Jolla, CA
No Relevant Financial Relationships to Disclose
Amber R. Lemons, PharmD, BCPP
Director, Educational Strategy
Clinical Care Options
Littleton, CO
No Relevant Financial Relationships to Disclose
Linda D. Logan, PharmD, BCACP, BCPP, BCPS
Public Service Associate
University of Georgia
Athens, GA
Educational Grants, Research Grants or Contracts: HRSA Graduate Psychology Education Grant, CPNP Foundation Student Grant (Advisor),
UGA College Pharmacy Ansel Fund
Megan Maroney, PharmD, BCPP
Clinical Associate Professor
Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey
Long Branch, NJ
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Pharmacy Times - speaker and medical writing honoraria,
Otsuka Pharmaceuticals - Excel Speakers Bureau (former, through March 2022), Novus Medical Education - consultant/medical writing,
Monica Mathys, PharmD, BCGP, BCPP
Professor
Texas Tech University School of Pharmacy
Dallas, TX
Non-Financial Interests: CPNP Foundation Board member
Jessica L. Mulhollan, PharmD, BCPP
Clinical Pharmacy Specialist, Substance Use Disorders and Mental Health Clinical Pharmacy Supervisor
Louis Stokes Cleveland VA Medical Center
Cleveland, OH
No Relevant Financial Relationships to Disclose
Kristen Neumeister, PharmD, BCPP
Clinical Pharmacist
North Texas State Hospital
Fort Worth, TX
No Relevant Financial Relationships to Disclose
Megan O'Connell, PharmD, BCPP
Advanced Practice Pharmacist - Psychiatry
University of Maryland - Clifton T. Perkins Hospital
jessup, MD
No Relevant Financial Relationships to Disclose
Melissa C. Palmer, PharmD, BCPP, BCPS
Clinical Pharmacy Specialist - Mental Health
Alaska VA Healthcare System
Anchorage, AK
No Relevant Financial Relationships to Disclose
Brittany L. Parmentier, PharmD, BCPS, BCPP
Clinical Pharmacy Specialist in Psychiatry
The Harris Center for Mental Health and IDD
Houston, TX
No Relevant Financial Relationships to Disclose
Jake R. Peters, PharmD, BCPP, BCPS
Assistant Professor of Pharmacy Practice/Clinical Pharmacy Specialist - Psychiatry
Butler University College of Pharmacy/Indiana University Health
Indianapolis, IN
No Relevant Financial Relationships to Disclose
Sarah J. Popish, PharmD, BCPP
VA PBM Academic Detailing Services, Program Manager
Department of Veterans Affairs
Sarasota, FL
No Relevant Financial Relationships to Disclose
Kara R. Wong, PharmD, BCPP
Chair
Clinical Pharmacist Practitioner, Mental Health
Minneapolis VA Health Care System
Minneapolis, MN
No Relevant Financial Relationships to Disclose
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
In accordance with the Food and Drug Administration (FDA), it is disclosed that there is the potential for discussions concerning off-label uses of a commercial product/devices during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in this activity. Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacists can obtain 5 hours of ACPE credit and 5 hours of BCPP Recertification credit by successfully completing the online Clinical Application Series examination.
Kara R. Wong, PharmD, BCPP